Joshua Nathaniel Silverman is a businessperson who founded Iroquois Capital Management LLC and Parkfield Funding LLC and who has been at the head of 5 different companies.
He occupies the position of Chairman for Akers Biosciences, Inc., Chairman of AYRO, Inc., Chairman for Neurotrope Bioscience, Inc. and Chairman of Neurotrope, Inc.
He is also on the board of Marker Therapeutics, Inc., Protagenic Therapeutics, Inc., Crellin Capital LLC and Petros Pharmaceuticals, Inc. and Managing Member at Parkfield Funding LLC.
In his past career Joshua Nathaniel Silverman occupied the position of Co-Chief Investment Officer for Vertical Ventures LLC, Managing Member at Iroquois Capital Management LLC and Co-Chief Investment Officer of Iroquois Capital LP (a subsidiary of Iroquois Capital Management LLC) and Chairman at DropCar, Inc.
He received an undergraduate degree from Lehigh University.